| NET LOSS PER SHARE OF COMMON STOCK |
NOTE 12. NET LOSS PER SHARE OF COMMON STOCK
Basic and diluted net loss per share is computed
by dividing net loss attributable to stockholders by the weighted average number shares of common stock outstanding during the period
and shares issuable for vested restricted stock units. Potentially dilutive outstanding shares of common stock equivalents were excluded
from the computation of diluted net loss per share for loss periods presented because including them would have been antidilutive.
A reconciliation of the numerator and denominator
used in the calculation of basic and diluted net loss per share attributable to stockholders follows:
| Schedule of reconciliation of basic and diluted net loss per share | |
| | |
| |
| | |
Three Months Ended June 30, | |
| | |
2024 | | |
2023 | |
| Numerator: | |
| | |
| |
| Net (loss) allocable to common stockholders used to compute basic and diluted loss per common share | |
$ | (1,238,077 | ) | |
$ | (1,464,557 | ) |
| Denominator: | |
| | | |
| | |
| Weighted average shares outstanding used to compute basic and dilutive loss per share | |
| 8,208,281 | | |
| 505,485 | |
| Weighted average shares issuable for vested restricted stock units | |
| 8,743 | | |
| 12,494 | |
| | |
$ | 8,217,024 | | |
$ | 517,979 | |
| |
Six Months Ended June 30, | |
| | |
2024 | | |
2023 | |
| Numerator: | |
| | |
| |
| Net (loss) allocable to common stockholders used to compute basic and diluted loss per common share | |
$ | (3,637,180 | ) | |
$ | (2,648,017 | ) |
| Denominator: | |
| | | |
| | |
| Weighted average shares outstanding used to compute basic and dilutive loss per share | |
| 6,817,419 | | |
| 498,415 | |
| Weighted average shares issuable for vested restricted stock units | |
| 12,406 | | |
| 9,084 | |
| | |
$ | 6,829,825 | | |
$ | 507,499 | |
The following outstanding potentially dilutive
securities were excluded from the weighted average calculation of dilutive loss per share attributable to common stockholders because
their impact would have been antidilutive for the period presented:
| Schedule of anti-dilutive securities excluded from computation of earnings per share | |
June 30, 2024 | | |
June 30, 2023 | |
| | |
| | |
| |
| Warrants | |
| 10,666,674 | | |
| 219,910 | |
| Restricted stock units | |
| 4,853 | | |
| 43,276 | |
| Stock options | |
| 169,458 | | |
| 171,176 | |
| | |
| 10,840,985 | | |
| 434,362 | |
|